porcin
reproduct
respiratori
syndrom
prr
respons
greater
million
direct
loss
us
pork
industri
annual
caus
agent
prr
viru
prrsv
envelop
positivesens
ribonucl
acid
rna
viru
belong
famili
arterivirida
two
known
prrsv
genotyp
european
type
north
american
type
ii
vari
interand
intragenotyp
genet
antigen
divers
signifi
high
mutagen
natur
viru
sinc
modifi
live
prrsmlv
inactiv
prrsv
vaccin
use
control
prr
remain
unsuccess
moreov
prrsmlv
implic
spread
mutat
vaccin
viru
suscept
pig
avail
inactiv
vaccin
safe
poorli
immunogen
therefor
develop
potent
inactiv
prrsv
vaccin
warrant
limit
associ
current
prrsvkill
vaccin
antigen
solubl
natur
poorli
immunogen
viral
protein
degrad
proteolyt
enzym
insuffici
antigen
mass
vaccin
formul
etc
sinc
prrsv
enter
host
primarili
respiratori
genit
mucos
surfac
deliveri
prrsv
vaccin
noninvas
intranas
rout
induc
robust
local
mucos
immun
appear
benefici
moreov
primari
target
cell
prrsv
alveolar
interstiti
macrophag
viru
caus
diseas
primarili
lung
intranas
immun
effici
stimul
protect
immun
respons
lung
also
elicit
immun
respons
distant
site
gastric
genit
mucosa
ultraviolet
uv
chemic
eg
binari
ethylenimin
inactiv
prrsv
preserv
immunogen
epitop
uvor
binari
ethylenimineinactiv
prrsv
sever
advantag
prrsmlv
unlik
live
prrsv
inactiv
viru
downregul
secret
import
innat
cytokin
interferon
ifn
inactiv
procedur
preserv
viral
neutral
epitop
abrog
develop
regulatori
tcell
subset
howev
deliveri
inactiv
viru
alon
vaccin
formul
efficaci
need
coupl
potent
adjuv
previous
establish
adjuv
effect
mycobacterium
tuberculosi
tb
wholecel
lysat
wcl
prrsmlv
tb
wcl
endotoxinfre
extract
contain
watersolubl
compon
bacterium
shown
possess
potent
adjuv
effect
rodent
guinea
pig
rabbit
importantli
unlik
complet
freund
adjuv
tb
wcl
free
waterinsolubl
toxic
cellwal
compon
bacterium
therefor
tb
wcl
caus
toxic
granulomat
inflammatori
reaction
site
inject
inocul
compon
tb
wcl
heat
shock
protein
pe
proglu
ppe
proproglu
shown
possess
potent
adjuv
activ
drive
primarili
thelper
th
respons
biodegrad
biocompat
nontox
repetit
polym
poli
lacticcoglycol
acid
plga
base
micronanoparticl
np
use
wide
target
drug
vaccin
deliveri
moreov
plga
us
food
drug
administrationand
european
medicin
agencyapprov
polym
variou
human
applic
solubl
vaccin
antigen
entrap
plga
np
size
shown
protect
encas
antigendrug
enzymat
ionic
degrad
vivo
immun
np
nm
size
rang
vaccin
enhanc
product
longlast
antigenspecif
tcell
respons
product
highaffin
neutral
antibodi
intranas
deliv
particul
antigen
sampl
readili
mucos
mcell
nasal
lymphoid
tissu
deliv
underli
profession
antigenpres
cell
apc
respiratori
tract
recent
shown
singledos
plga
npentrap
inactiv
prrsv
npkag
vaccin
deliv
intranas
pig
elicit
antiprrsv
immun
respons
order
reinforc
efficaci
npkag
vaccin
slightli
modifi
vaccin
constitu
coadminist
vaccin
potent
adjuv
tb
wcl
twice
intranas
vaccin
pig
enhanc
crossprotect
humor
cellmedi
immun
respons
challeng
prrsv
detect
associ
complet
clearanc
detect
replic
challeng
heterolog
viru
viral
rna
blood
marc
cell
use
prepar
prrsv
stock
assay
cell
maintain
dulbecco
modifi
eagl
medium
dmem
contain
fetal
bovin
serum
viru
infect
dmem
hors
serum
use
north
american
prototyp
prrsv
strain
use
vaccin
prepar
provid
dr
eric
nelson
south
dakota
state
univers
usa
prrsv
provid
dr
michael
murtaugh
univers
minnesota
usa
tb
wcl
prepar
previous
describ
prepar
vaccin
antigen
plga
nanoparticlebas
vaccin
formul
prrsv
strain
grown
uvkil
inactiv
kag
describ
previous
plga
np
entrap
kag
npkag
tb
wcl
npm
tb
wcl
prepar
use
doubleemuls
method
wow
previous
describ
modif
nanoparticl
prrsv
vaccin
crossprotect
phosphatebuff
salin
pb
mix
ml
polyvinyl
alcohol
molecular
weight
sigmaaldrich
prepar
mm
acid
buffer
ph
sucros
magnesium
hydroxid
ml
ad
plga
polym
solut
probeson
second
branson
sonifi
emerson
industri
autom
danburi
ct
usa
duti
cycl
output
control
three
result
waterinoil
wo
emuls
divid
two
tube
ml
polyvinyl
alcohol
ml
poloxam
solut
ad
tube
sonic
second
obtain
final
wow
emuls
content
tube
pool
stir
hour
magnet
stirrer
rpm
evapor
solvent
tube
centrifug
g
router
beckman
coulter
pasadena
ca
usa
pellet
contain
np
wash
steril
distil
water
minut
three
time
final
np
suspend
ml
sucros
solut
freezedri
hour
lyophil
powder
store
protein
entrap
np
estim
describ
previous
morpholog
npkag
visual
use
philip
amsterdam
netherland
scan
electron
microscop
kv
magnif
size
distribut
shamor
kagentrap
np
measur
use
nicomp
particl
sizer
particl
size
system
port
richey
fl
usa
zeta
potenti
np
determin
zetap
brookhaven
instrument
holtsvil
ny
usa
proteinreleas
profil
npkag
vaccin
determin
previous
describ
briefli
mg
npkag
suspend
ml
steril
pb
centrifug
g
minut
supernat
collect
estim
burst
releas
pellet
contain
npkag
resuspend
ml
pb
harvest
supernat
collect
day
store
day
remain
npkag
lyse
use
lysi
buffer
recov
protein
protein
concentr
sampl
estim
bicinchonin
acid
assay
vitro
uptak
npkag
pam
cell
npkag
vaccin
contain
prrsv
kag
suspend
ml
roswel
park
memori
institut
medium
incub
porcin
alveolar
macrophag
pam
cell
american
type
cultur
collect
manassa
va
usa
minut
hour
control
kag
sham
nptreat
pam
cell
marc
cell
prrsv
infect
cell
infect
hour
prrsv
strain
cell
wash
fix
aceton
incub
prrsv
monoclon
antibodi
mab
rural
technolog
brook
sd
usa
follow
antimous
immunoglobulin
ig
g
hl
alexa
life
technolog
carlsbad
ca
usa
observ
fluoresc
microscop
convent
larg
white
duroc
crossbr
specif
ic
pathogenfre
wean
week
piglet
procur
swineherd
seroneg
prrsv
porcin
respiratori
coronaviru
transmiss
gastroenter
viru
porcin
circoviru
antibodi
total
pig
randomli
divid
one
ten
group
three
pigsgroup
vaccin
indic
vaccin
adjuv
formul
tabl
everi
dose
prrsv
vaccin
either
low
high
mg
semipurifi
viral
protein
equival
approxim
tissuecultur
infect
dose
tcid
kill
prrsv
respect
adjuv
tb
wcl
mgdosepig
vaccin
adjuv
either
encapsul
np
unencapsul
inocul
intranas
twice
interv
mlpig
tabl
except
pig
group
group
challeng
postvaccin
day
virul
heterolog
north
american
prrsv
type
ii
strain
tcid
pig
genet
highli
diverg
ident
vaccin
strain
adjuv
vaccin
entrap
separ
combin
immun
dose
adjuv
npkag
test
efficaci
earlier
pig
kill
postchalleng
pc
day
pig
monitor
daili
respiratori
diseas
rectal
temperatur
bodi
weight
record
everi
third
day
postchalleng
anim
maintain
food
water
ad
libitum
sampl
collect
pig
kill
per
approv
protocol
institut
anim
care
use
committe
ohio
state
univers
prrsvspecif
antibodi
respons
determin
describ
previous
briefli
enzymelink
immunosorb
assay
elisa
plate
coat
pretitr
semipurifi
ag
prrsvrecombin
n
protein
mean
optic
densiti
od
valu
tenfolddilut
prrsvneg
plasma
sampl
plu
twice
standard
deviat
consid
positiveneg
cutoff
reciproc
highest
dilut
plasma
sampl
show
od
valu
cutoff
od
consid
end
titer
prrsvspecif
igg
igg
antibodi
plasma
sampl
analyz
describ
previous
avid
prrsvspecif
antibodi
lung
blood
prrsvspecif
ic
antibodi
avid
determin
describ
previous
modif
briefli
plasma
sampl
ad
prrsv
agscoat
elisa
plate
incub
plate
wash
four
time
serial
twofold
dilut
nh
cn
incub
minut
room
temperatur
remain
procedur
follow
describ
earlier
estim
prrsvspecif
antibodi
od
valu
test
sampl
nh
cnuntreat
well
consid
absorb
testsampl
od
valu
nh
cntreat
well
compar
untreat
well
correspond
sampl
estim
retain
agab
complex
express
percentag
absorb
determin
prrsvspecif
antibodi
respons
level
virusspecif
igg
igg
antibodi
plasma
sampl
analyz
describ
previous
modif
briefli
kill
semipurifi
prrsv
ag
coat
plate
block
plate
serial
tenfold
dilut
plasma
sampl
platebound
virusspecif
igg
igg
detect
use
mous
antipig
igg
igg
abd
serotec
biorad
laboratori
hercul
ca
usa
dilut
respect
subsequ
design
well
treat
goat
antimous
horseradish
peroxidas
sigmaaldrich
dilut
reaction
develop
use
substrat
stop
use
phosphor
acid
read
od
calcul
prrsvspecif
igg
igg
antibodi
level
test
sampl
od
valu
dilut
consid
analysi
recal
cytokin
respons
peripher
blood
mononuclear
cell
pbmc
stimul
semipurifi
kill
prrsv
ag
cell
unstimul
stimul
phytohemagglutinin
sigmaaldrich
serv
control
cultur
supernat
harvest
hour
analyz
proinflammatori
interleukin
il
immunosuppress
cytokin
elisa
describ
previous
phenotyp
frequenc
lymphoid
myeloid
cell
popul
event
immunostain
pbmc
determin
flow
cytometri
describ
previous
intracellular
stain
bd
bioscienc
san
jose
ca
usa
ad
last
hour
incub
pbmc
unstimul
stimul
prrsv
ag
describ
pbmc
first
surfacelabel
use
pig
lymphocytespecif
mab
directli
conjug
differ
fluorochrom
cell
fix
paraformaldehyd
permeabil
cellpermeabil
buffer
deioniz
water
pb
ca
mg
formaldehyd
solut
saponin
overnight
cell
wash
stain
fluorochromeconjug
pig
nanoparticl
prrsv
vaccin
crossprotect
isotyp
control
mab
bd
bioscienc
saponin
contain
fluorescenceactiv
cellsort
fac
buffer
immunostain
cell
acquir
use
fac
aria
ii
bd
bioscienc
flow
cytomet
analyz
use
flowjo
tree
star
ashland
usa
softwar
specif
immun
popul
frequenc
present
percentag
total
lymphocyt
myeloid
cell
determin
prrsv
load
rna
copi
virusneutr
titer
prrsv
titer
virusneutr
vn
antibodi
titer
plasma
sampl
analyz
indirect
immunofluoresc
assay
briefli
viru
titrat
confluent
monolay
marc
cell
microtit
plate
treat
tenfold
dilut
plasma
hour
prr
viral
titer
millilit
plasma
virusspecif
vn
titer
calcul
prrsv
rna
copi
number
detect
millilit
plasma
qrtpcr
previous
describ
vn
assay
twofold
serial
dilut
plasma
sampl
incub
one
prrsv
strain
tcid
prrsv
access
tcid
tcid
data
express
mean
standard
error
mean
three
pig
statist
analys
perform
oneway
analysi
varianc
follow
tukey
ttest
unpair
ttest
compar
certain
result
use
graphpad
softwar
la
jolla
ca
usa
comparison
perform
differ
treatment
group
consid
statist
signific
indic
letter
aj
mention
group
versu
group
b
group
versu
group
c
group
versu
group
group
versu
group
e
group
versu
group
f
group
versu
group
g
group
versu
group
h
group
versu
group
group
versu
group
j
group
versu
group
potenc
npmediat
deliveri
drug
vaccin
depend
load
capac
size
entrap
effici
killedprrsv
antigen
kag
tb
wcl
np
shamand
entrap
np
circular
shape
figur
dynam
light
scatter
np
determin
diameterbas
distribut
mean
diamet
standard
deviat
sham
np
npkag
npm
tb
wcl
nm
respect
sham
np
npm
tb
wcl
npkag
size
rang
nm
interestingli
differ
among
three
np
respect
surfac
electrostat
potenti
mv
measur
zeta
potenti
indic
differenti
surfac
charg
entrap
protein
influenc
net
electrostat
potenti
final
form
differ
np
reconstitut
np
entrap
agent
pb
surfaceassoci
agent
releas
immedi
solut
time
zero
call
burst
releas
freshli
prepar
week
old
npkag
burst
releas
hour
reconstitut
protein
releas
figur
day
entrap
vaccin
protein
releas
figur
unlys
npkag
remain
viral
protein
recov
store
npkag
year
old
burst
releas
releas
protein
day
detect
suggest
plga
np
stabli
retain
entrap
vaccin
protein
year
allow
sustain
puls
releas
entrap
vaccin
ag
normal
physiolog
condit
period
sever
week
prrsv
infect
pig
viru
mainli
infect
pam
treatment
pam
cell
unentrap
kag
period
hour
result
neglig
uptak
cell
figur
contrast
uptak
npkag
pam
cell
start
earli
minut
posttreat
reach
peak
minut
follow
gradual
reduct
fluoresc
signal
hour
posttreat
figur
ii
might
attribut
degrad
releas
vaccin
ag
np
insid
pam
cell
sham
nptreat
untreat
pam
cell
show
immunofluoresc
signal
figur
iii
iv
control
prrsvinfect
marc
cell
virusspecif
green
signal
figur
v
enhanc
product
prrsvspecif
igg
blood
adjuv
npkagimmun
pig
prrsv
infect
pig
induc
massiv
bcell
polyclon
lymphoplasia
result
hypergammaglobulinemia
result
indic
total
igm
igg
iga
level
plasma
compar
viruschalleng
pig
intern
journal
nanomedicin
submit
manuscript
wwwdovepresscom
binjawadagi
et
al
group
data
shown
prrsvspecif
igg
respons
significantli
higher
plasma
group
pig
receiv
low
dose
compar
group
pc
day
compar
group
pc
day
respect
figur
high
dose
vaccin
categori
group
pig
significantli
higher
virusspecif
igg
titer
compar
group
test
pc
day
compar
group
pc
day
compar
group
pc
day
figur
furthermor
evalu
prrsvspecif
igg
respons
recombin
structur
protein
found
compar
level
igg
titer
pig
group
viral
surfac
glycoprotein
figur
prrsv
nucleocapsid
n
protein
specif
igg
antibodi
howev
significantli
higher
group
pig
compar
test
group
figur
h
overal
result
indic
significantli
increas
level
prrsvspecif
antibodi
respons
npkag
tb
wclvaccin
pig
adjuv
npkag
induc
balanc
respons
typic
kill
vaccin
elicit
predominantli
respons
npbase
vaccin
drive
either
respons
respons
pig
higher
level
igg
subisotyp
igg
igg
indic
respons
respect
therefor
quantifi
prrsvspecif
igg
igg
level
blood
level
prrsvspecif
igg
igg
plasma
pc
day
pig
group
remain
low
compar
level
significantli
higher
pc
day
group
pig
receiv
high
vaccin
dose
compar
group
figur
assess
respons
nanoparticl
prrsv
vaccin
crossprotect
ratio
igg
igg
assess
wherein
ratio
indic
respons
respect
group
pig
pc
day
respons
ratio
close
detect
plasma
pig
group
antibodi
respons
detect
figur
similar
trend
antibodi
respons
observ
pig
receiv
vaccin
dose
figur
c
thu
data
suggest
adjuv
npkag
elicit
immun
respons
pig
adjuv
npkag
induc
highavid
prrsvspecif
antibodi
bind
strength
heterogen
polyclon
antibodi
cognat
antigen
defin
avid
differ
avid
igg
plasma
among
test
group
figur
b
e
f
howev
significantli
higher
pig
group
compar
group
pig
receiv
low
dose
vaccin
compar
group
highdos
group
respect
figur
g
overal
data
suggest
prrsvspecif
antibodi
enhanc
avid
produc
pc
day
adjuv
npkag
vaccin
pig
neutral
antibodi
may
play
import
role
clearanc
prrsv
infect
report
debat
import
vn
antibodi
prrsv
clearanc
due
absenc
viremia
pig
prior
detect
vn
antibodi
serum
studi
plasma
sampl
group
pig
vaccin
dose
significantli
higher
vn
titer
compar
test
group
figur
h
group
pig
compar
lowdos
vaccin
highdos
vaccin
elicit
steadi
increas
vn
titer
figur
vn
titer
prrsv
strain
remain
undetect
plasma
pc
day
group
pig
receiv
high
dose
vaccin
vn
titer
eight
detect
pc
day
data
shown
result
indic
adjuv
npkag
potenti
elicit
broadli
crossreact
neutral
antibodi
respons
cytokin
import
indic
respons
observ
significantli
increas
secret
restimul
pbmc
group
pig
receiv
high
dose
vaccin
compar
test
group
figur
b
secret
proinflammatori
cytokin
nanoparticl
prrsv
vaccin
crossprotect
restimul
pbmc
highdos
group
pig
significantli
reduc
compar
group
anim
figur
interestingli
secret
immunosuppress
cytokin
pbmc
recal
respons
significantli
reduc
group
pig
compar
group
either
vaccin
dose
figur
f
pbmc
isol
vaccin
viruschalleng
pig
immunostain
analyz
determin
frequenc
lymphoid
myeloid
immun
cell
lymphocyt
subset
compar
respons
cell
unstimul
restimul
ag
help
detect
virusspecif
lymphocyt
respons
prrsv
antigenspecif
recal
respons
detect
lymphocyt
subset
figur
howev
group
pig
vaccin
dose
signific
increas
lymphocyt
respons
stimul
compar
unstimul
cell
detect
figur
suggest
cell
prime
adequ
vivo
group
pig
irrespect
vitro
stimul
lymphocyt
pig
group
increas
frequenc
lymphocyt
subset
like
natur
killer
nk
cell
figur
prrsvantigen
stimul
group
pig
show
significantli
increas
frequenc
total
cell
figur
e
vaccin
dose
virusspecif
lymphocyt
respons
compar
among
test
pig
group
stimul
cell
highdos
group
pig
significantli
increas
compar
group
group
respect
figur
cell
significantli
higher
group
pig
compar
group
similar
trend
also
observ
group
pig
figur
increas
frequenc
activ
cell
group
pig
detect
compar
group
tabl
significantli
increas
tcell
popul
group
pig
detect
compar
group
pig
figur
similar
trend
cell
observ
lowdos
pig
data
statist
signific
figur
although
signific
differ
total
nk
cell
frequenc
figur
r
signific
increas
nk
cell
frequenc
detect
pig
group
compar
test
group
figur
addit
dendrit
cell
dc
rich
popul
slaii
significantli
higher
group
pig
receiv
high
dose
vaccin
compar
test
group
figur
adjuv
npkagvaccin
pig
detect
replic
prrsv
viral
rna
absent
order
assess
efficaci
vaccin
combin
viral
clearanc
estim
heterolog
prrsvchalleng
pig
blood
pig
group
receiv
lowdos
vaccin
significantli
reduc
prrsv
titer
detect
compar
group
pc
day
figur
group
pig
receiv
high
dose
vaccin
detect
replic
prrsv
complet
absent
blood
viruschalleng
pig
test
pc
day
figur
howev
prrsv
rna
copi
plasma
twoto
threefold
less
group
pig
compar
group
pc
day
figur
abil
stimul
herd
immun
hallmark
mucos
vaccin
suffici
level
pathogenspecif
humor
cellmedi
immun
respons
elicit
simultan
mucos
system
site
help
neutral
infecti
viru
effect
reduc
virul
limit
diseas
transmiss
far
prrsvspecif
respons
induc
wide
use
vaccin
administ
parenter
rout
fail
protect
pig
complet
infect
caus
heterolog
field
strain
reinfect
sinc
prrsv
primarili
respiratori
tract
pathogen
intranas
deliveri
vaccin
appear
advantag
among
mucos
rout
intranas
deliveri
npbase
vaccin
induc
higher
prolong
durat
igg
iga
antibodi
respons
compar
rectal
oral
intramuscular
rout
immun
plga
np
abil
mediat
activ
matur
antigen
present
apc
facilit
sustain
releas
vaccin
ag
mediat
induct
robust
band
tcell
respons
use
plga
entrap
uvinactiv
prrsv
ag
observ
vitro
vaccin
proteinreleas
profil
npkag
compar
anoth
studi
size
surfac
characterist
np
play
import
role
opson
clearanc
intern
journal
nanomedicin
submit
manuscript
wwwdovepresscom
nanoparticl
prrsv
vaccin
crossprotect
apc
recent
studi
shown
magnitud
tcell
respons
depend
durat
avail
vaccin
ag
effector
cell
also
lesser
extent
memori
cell
requir
sustain
antigen
stimul
expans
plga
np
promot
crosspresent
vaccin
antigen
due
phagosomedisrupt
properti
insid
dc
macrophag
result
enhanc
deliveri
antigen
cytosol
major
histocompat
complex
class
load
increas
tcell
effector
respons
also
help
gener
memori
tcell
respons
clearanc
invad
pathogen
consist
studi
rapid
uptak
npkag
vaccin
pam
cell
notic
suggest
abil
plga
np
deliv
vaccin
ag
rapidli
effici
target
cell
clinic
mock
group
kag
group
vaccin
viruschalleng
pig
irregular
fever
reduc
feed
intak
first
week
postchalleng
physiolog
chang
absent
pig
group
though
viru
virul
field
e
dot
line
isotyp
control
solid
line
specif
stain
stimul
pbmc
prrsv
ag
immunostain
use
indic
cellsurfac
marker
show
lymphocyt
subset
f
n
g
h
p
q
j
r
nk
k
cell
analyz
pc
also
apc
popul
macrophagesrich
popul
slaii
l
dcrich
popul
slaii
u
analyz
bar
indic
averag
frequenc
indic
cell
three
pig
sem
asterisk
indic
statist
signific
differ
two
indic
pig
group
unpair
ttest
appli
compar
data
ac
data
oneway
analysi
varianc
follow
tukey
ttest
use
abbrevi
ifn
interferon
apc
antigenpres
cell
cd
cluster
differenti
prrsv
porcin
reproduct
respiratori
syndrom
viru
kag
killedinactiv
antigen
npkag
nanoparticleentrap
inactiv
prrsv
vaccin
pc
postchalleng
pbmc
peripher
blood
mononuclear
cell
il
interleukin
nk
natur
killer
sla
swine
leukocyt
antigen
dc
dendrit
cell
sem
standard
error
mean
chal
challeng
wcl
wholecel
lysat
myco
bacterium
tuberculosi
ag
antigen
mf
macrophag
kinet
size
rang
npkag
nm
diamet
ideal
uptak
mucos
cell
apc
aim
enhanc
immunogen
npkag
vaccin
incorpor
reagent
vaccin
compar
earlier
studi
chang
npkag
vaccin
known
provid
hydrophil
natur
contribut
polaxam
np
facilit
easi
uptak
np
apc
sucros
use
protein
stabil
mg
oh
help
buffer
acid
ph
gener
hydrolysi
plga
insid
apc
similar
modifi
np
vaccin
contain
human
immunodefici
peptid
deliv
intranas
mice
elicit
enhanc
prolong
igg
iga
antibodi
respons
compar
micronanoparticl
plga
releas
entrap
antigen
much
slower
rate
elicit
robust
effector
memori
immun
respons
entrap
prrsv
antigen
retain
insid
np
sever
day
physiolog
condit
indic
effici
npkag
vaccin
preserv
entrap
ag
vivo
prolong
period
phagocytos
strain
absenc
pronounc
clinic
prr
symptom
viruschalleng
pig
could
due
use
repeat
tissu
culturepassag
viru
desir
vaccin
ag
adjuv
np
consid
ad
benefit
deliveri
antigen
adjuv
apc
howev
entrap
separ
difficult
differenti
quantifi
entrap
vaccin
protein
adjuv
tb
wcl
princip
contain
protein
howev
futur
evalu
combin
entrap
vaccin
demonstr
tb
wcl
adjuv
npkag
vaccin
formul
augment
crossprotect
immun
respons
heterolog
prrsv
confirm
benefit
npmediat
vaccinedeliveri
system
pig
consist
other
find
overal
crossprotect
respons
elicit
npkag
plu
tb
wcl
formul
pig
indic
follow
import
immun
correl
absenc
detect
challeng
heterolog
replic
prrsv
pc
day
associ
threefold
reduct
viral
rna
load
increas
level
prrsv
vn
titer
associ
increas
virusspecif
antibodi
respons
enhanc
antibodi
avid
time
balanc
respons
significantli
increas
frequenc
cell
downregul
secret
immunosuppress
cytokin
compar
level
total
quantiti
antibodi
detect
prrsvchalleng
pig
significantli
enhanc
level
antiprrsv
antibodi
respons
detect
adjuv
npkagvaccin
pig
enhanc
avid
polyclon
antibodi
vaccin
infect
anim
posit
correl
vn
titer
avid
prrsvspecif
igg
plasma
group
pig
gradual
increas
becom
significantli
higher
pc
day
npkag
plu
tb
wclvaccin
pig
attribut
gradual
domin
highaffin
bcell
clone
np
shown
interact
pathogenrecognit
receptor
apc
especi
b
cell
lead
affin
matur
product
highavid
antibodi
virusspecif
neutral
antibodi
play
import
role
clearanc
prrsv
viremia
limit
viral
uptak
target
cell
mean
vn
titer
adjuv
npkagvaccin
pig
higher
propos
titer
eight
clear
viremia
week
postchalleng
clearanc
detect
replic
prrsv
absent
earli
day
postchalleng
could
attribut
earli
appear
vn
antibodi
possibl
target
put
neutral
epitop
present
prrsv
protein
consid
analyz
viral
load
earlier
time
point
futur
studi
normal
prrsvspecif
vn
activ
detect
week
infect
pig
significantli
vari
strain
prrsv
adjuv
npkagvaccin
pig
vn
titer
detect
week
postchalleng
later
steadili
increas
thu
use
npbase
vaccin
approach
possibl
induc
high
level
longlast
prrsv
vn
titer
elicit
effect
memori
respons
inactiv
vaccin
elicit
predominantli
respons
npbase
vaccin
shown
drive
either
respons
adjuv
npkagvaccin
pig
balanc
respons
observ
indic
increas
level
virusspecif
igg
igg
product
enhanc
respons
nanoparticl
prrsv
vaccin
crossprotect
although
detect
signif
icantli
increas
frequenc
differ
lymphocyt
subset
group
pig
pbmc
significantli
increas
frequenc
restimul
compar
unstimul
cell
detect
cell
popul
suggest
possibl
strong
cytotox
tcell
respons
pig
sinc
detect
increas
compar
frequenc
cell
lymphocyt
subset
stimul
unstimul
pbmc
group
pig
data
also
indic
teffector
cell
nk
cell
activ
secret
part
respons
prrsvchalleng
infect
vivo
data
cell
respons
pig
postvaccin
prior
challeng
difficult
show
exclus
challeng
virusinduc
respons
observ
necess
immedi
avail
solubl
adjuv
site
npvaccin
deliveri
incomplet
viru
clearanc
inadequ
immun
respons
detect
pig
coadminist
vaccin
agand
adjuvantentrap
np
result
consist
earlier
report
wherein
plga
encapsul
vaccin
ag
hepat
b
core
antigen
adjuv
monophosphoryl
lipid
fail
increas
antibodi
respons
anoth
advantag
npbase
vaccin
abil
reduc
greatli
requir
vaccin
dose
recent
studi
estim
dose
plga
npbase
vaccin
could
reduc
much
time
compar
administr
freund
incomplet
adjuv
emulsifi
vaccin
although
pig
vaccin
adjuv
npkag
vaccin
substanti
level
immun
respons
elicit
viru
clearanc
satisfactori
indic
need
suitabl
vaccin
dose
better
viral
clearanc
plgamedi
vaccinedeliveri
system
get
global
recognit
due
flexibl
engin
particl
size
charg
content
celltarget
properti
prove
highli
effect
deliveri
subunit
inactiv
wholepathogen
vaccin
especi
mucos
site
conclus
intranas
deliveri
plga
npentrap
inactiv
prrsv
vaccin
adjuv
solubl
tb
wcl
potenti
induc
crossprotect
immun
respons
pig
futur
studi
aim
elucid
durat
crossprotect
immun
respons
vaccin
pig
detect
challeng
prrsv
lymphoid
tissu
addit
fraction
tb
wcl
identifi
import
compon
involv
potent
adjuv
effect
evalu
immunostimulatori
effect
entrap
tb
lysat
compar
solubl
lysat
use
porcin
dc
macrophag
also
consid
